Abstract
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1097/cm9.0000000000002570
Journal: Chinese medical journal | Publication Date: Mar 20, 2023 |
Citations: 1 | License type: CC BY-NC-ND 4.0 |
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma.
Join us for a 30 min session where you can share your feedback and ask us any queries you have